Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA.
Garcia-Gisbert N, Garcia-Ávila S, Merchán B, Salido M, Fernández-Rodríguez C, Gibert J, Fernández-Ibarrondo L, Camacho L, Lafuente M, Longarón R, Espinet B, Vélez P, Pujol RM, Andrade-Campos M, Arenillas L, Salar A, Calvo X, Besses C, Bellosillo B. Garcia-Gisbert N, et al. Among authors: lafuente m. Blood Adv. 2022 May 24;6(10):3178-3188. doi: 10.1182/bloodadvances.2021006565. Blood Adv. 2022. PMID: 35192693 Free PMC article.
Evaluation of 4 prognostic indices in follicular lymphoma treated in first line with immunochemotherapy.
Rodríguez-Sevilla JJ, Fernández-Rodríguez C, Bento L, Diez-Feijóo R, Pinzón S, Gibert J, Fernández-Ibarrondo L, Lafuente M, Ferrer A, Sánchez-González B, Gimeno E, Sainz J, Ramos R, García JF, Colomo L, Bellosillo B, Gutiérrez A, Salar A. Rodríguez-Sevilla JJ, et al. Among authors: lafuente m. Blood Adv. 2023 Apr 25;7(8):1606-1614. doi: 10.1182/bloodadvances.2022007949. Blood Adv. 2023. PMID: 36260737 Free PMC article.
Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
Diez-Feijóo R, Andrade-Campos M, Gibert J, Sánchez-González B, Fernández-Ibarrondo L, Fernández-Rodríguez C, Garcia-Gisbert N, Camacho L, Lafuente M, Vázquez I, Colomo L, Salar A, Bellosillo B. Diez-Feijóo R, et al. Among authors: lafuente m. Cancers (Basel). 2024 Jan 11;16(2):321. doi: 10.3390/cancers16020321. Cancers (Basel). 2024. PMID: 38254810 Free PMC article.
Combination Treatment of Recurrent Basilar Tip and Anterior Communicating Aneurysms With Transcirculation P1-P1 and Y Stenting Techniques: 2-Dimensional Operative Video.
Gaub M, Pathuri S, Gunaji R, Lafuente M, Birnbaum LA, Al Saiegh F, Mascitelli JR. Gaub M, et al. Among authors: lafuente m. Oper Neurosurg (Hagerstown). 2023 Dec 4. doi: 10.1227/ons.0000000000001022. Online ahead of print. Oper Neurosurg (Hagerstown). 2023. PMID: 38047641 No abstract available.
[Pediatric telecardiology experience in the COVID-19 pandemic context].
Foti ML, Stelmaszewski ÉV, Micheli DC, Lafuente MV, Mouratian M, Di Santo MV, Villa A. Foti ML, et al. Among authors: lafuente mv. Arch Cardiol Mex. 2023 Nov 6;93(Supl 6):108-114. doi: 10.24875/ACM.22000251. Arch Cardiol Mex. 2023. PMID: 37931895 Free article. Spanish.
Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study.
Ruiz-Moreno JM, Adán A, Lafuente M, Asencio Durán M, Arias Barquet L, García Layana A, Araiz Iribarren J. Ruiz-Moreno JM, et al. Among authors: lafuente m. Int Ophthalmol. 2023 Dec;43(12):4639-4649. doi: 10.1007/s10792-023-02864-2. Epub 2023 Sep 12. Int Ophthalmol. 2023. PMID: 37697082 Free PMC article.
166 results